Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 3
1993 1
1994 3
1995 2
1996 3
1997 2
1998 1
1999 1
2000 1
2002 3
2003 1
2005 2
2006 1
2007 1
2008 1
2009 6
2010 4
2011 1
2012 1
2015 3
2016 3
2017 2
2019 2
2020 4
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Results by year
Filters applied: . Clear all
Page 1
Ibrutinib for mantle cell lymphoma.
Tucker DL, Rule SA. Tucker DL, et al. Among authors: rule sa. Future Oncol. 2016 Feb;12(4):477-91. doi: 10.2217/fon.15.342. Epub 2016 Jan 13. Future Oncol. 2016. PMID: 26759179 Review.
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.
Morschhauser F, Dyer MJS, Walter HS, Danilov AV, Ysebaert L, Hodson DJ, Fegan C, Rule SA, Radford J, Cartron G, Bouabdallah K, Davies AJ, Spurgeon S, Rajakumaraswamy N, Li B, Humeniuk R, Huang X, Bhargava P, Jürgensmeier JM, Salles G. Morschhauser F, et al. Among authors: rule sa. Leukemia. 2021 Jul;35(7):2108-2113. doi: 10.1038/s41375-020-01108-x. Epub 2020 Dec 17. Leukemia. 2021. PMID: 33328591 Free PMC article. Clinical Trial. No abstract available.
Paranasal sinusitis following allogeneic bone marrow transplant.
Savage DG, Taylor P, Blackwell J, Chen F, Szydlo RM, Rule SA, Spencer A, Apperley JF, Goldman JM. Savage DG, et al. Among authors: rule sa. Bone Marrow Transplant. 1997 Jan;19(1):55-9. doi: 10.1038/sj.bmt.1700601. Bone Marrow Transplant. 1997. PMID: 9012932 Review.
Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia.
Danilov AV, Herbaux C, Walter HS, Hillmen P, Rule SA, Kio EA, Karlin L, Dyer MJS, Mitra SS, Yi PC, Humeniuk R, Huang X, Zhou Z, Bhargava P, Jürgensmeier JM, Fegan CD. Danilov AV, et al. Among authors: rule sa. Clin Cancer Res. 2020 Jun 15;26(12):2810-2818. doi: 10.1158/1078-0432.CCR-19-3504. Epub 2020 Mar 10. Clin Cancer Res. 2020. PMID: 32156743 Clinical Trial.
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.
Morschhauser F, Machiels JP, Salles G, Rottey S, Rule SAJ, Cunningham D, Peyrade F, Fruchart C, Arkenau HT, Genvresse I, Liu L, Köchert K, Shen K, Kneip C, Peña CE, Grevel J, Zhang J, Cisternas G, Reschke S, Granvil C, Awada A. Morschhauser F, et al. Among authors: rule saj. Mol Cancer Ther. 2020 Feb;19(2):468-478. doi: 10.1158/1535-7163.MCT-19-0466. Epub 2019 Oct 16. Mol Cancer Ther. 2020. PMID: 31619463 Clinical Trial.
Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.
Walter HS, Jayne S, Rule SA, Cartron G, Morschhauser F, Macip S, Karlin L, Jones C, Herbaux C, Quittet P, Shah N, Hutchinson CV, Fegan C, Yang Y, Mitra S, Salles G, Dyer MJS. Walter HS, et al. Among authors: rule sa. Blood. 2017 May 18;129(20):2808-2810. doi: 10.1182/blood-2017-02-765115. Epub 2017 Apr 4. Blood. 2017. PMID: 28377400 Free PMC article. Clinical Trial. No abstract available.
Chemotherapy in the community: what do patients want?
Pace E, Dennison S, Morris J, Barton A, Pritchard C, Rule SA. Pace E, et al. Among authors: rule sa. Eur J Cancer Care (Engl). 2009 Mar;18(2):209-15. doi: 10.1111/j.1365-2354.2008.01051.x. Eur J Cancer Care (Engl). 2009. PMID: 19267739 Clinical Trial.
48 results